Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Zomedica Pharmaceuticals Corp
(NY:
ZOM
)
0.1260
-0.0021 (-1.64%)
Streaming Delayed Price
Updated: 11:34 AM EDT, Aug 28, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Zomedica Pharmaceuticals Corp
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Zomedica Corp. (NYSE American: ZOM) Featured in Coverage of the EF Hutton Annual Global Conference
May 06, 2024
Via
Investor Brand Network
Zomedica Expands International Reach with CE Certification for VetGuardian(R) System
May 06, 2024
Via
ACCESSWIRE
Zomedica Strengthens Market Position with New Patents Issued for its TRUFORMA(R) Diagnostic Platform
May 02, 2024
Via
ACCESSWIRE
Zomedica to Report First Quarter 2024 Financial Results and Provide Business Update on May 9th at 4:30 p.m. ET
April 30, 2024
Via
ACCESSWIRE
Zomedica to Present at the Noble Capital Markets Virtual Healthcare Conference on April 17, 2024
April 09, 2024
Via
ACCESSWIRE
ZOM Stock Earnings: Zomedica Beats Revenue for Q4 2023
April 01, 2024
ZOM stock results show that Zomedica beat on revenue for the fourth quarter of 2023.
Via
InvestorPlace
Zomedica Reports Record Revenue of $7.3 Million for the Fourth Quarter and $25.2 Million for the Full Year 2023, Reflecting 33% Annual Growth; 69% Gross Margin and $100.5 Million in Liquidity
April 01, 2024
Via
ACCESSWIRE
Earnings Scheduled For April 1, 2024
April 01, 2024
Companies Reporting Before The Bell • Mach Natural Resources (NYSE:MNR) is projected to report quarterly earnings at $0.92 per share on revenue of $213.43 million.
Via
Benzinga
Zomedica to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update on Monday, April 1, 2024, at 4:30 p.m. ET
March 20, 2024
Via
ACCESSWIRE
Zomedica Announces Publication of Research Concluding TRUFORMA(R) Platform is More Accurate Diagnostic Test for Feline Hyperthyroidism than Chemiluminescent Immunoassay (CLIA) Platform
March 14, 2024
Via
ACCESSWIRE
Zomedica Provides NYSE American Listing Update
March 13, 2024
Via
ACCESSWIRE
Zomedica Announces Sponsorship of Educational Presentations at Fetch dvm360 Veterinary Conferences
March 12, 2024
Via
ACCESSWIRE
Zomedica Announces Publication of Case Series Highlighting Success with PulseVet(R) Shock Wave Therapy for Difficult to Treat Fibrotic Myopathy in Working Dogs
March 07, 2024
Via
ACCESSWIRE
Zomedica to Present at the Sidoti Small Cap Conference March 14, 2024
March 05, 2024
Via
ACCESSWIRE
3 High-Reward Penny Stocks to Uncover Big Gains
February 11, 2024
Dive into the realm of high-reward penny stocks. The article gives the insights you need to spot quality plays and make informed decisions.
Via
InvestorPlace
Zomedica Announces Sponsorship of Educational Presentations at Major Veterinary Health Conferences
February 08, 2024
Via
ACCESSWIRE
7 Penny Stocks to Buy on the Dip: February 2024
February 07, 2024
With the markets turning lower, these penny stocks to buy stand out as attractive options. Consider these seven stocks.
Via
InvestorPlace
Leading Independent Proxy Advisory Firm Glass Lewis Recommends Zomedica Shareholders Vote for the Share Consolidation (Reverse Stock Split)
February 06, 2024
Via
ACCESSWIRE
Zomedica to Host Virtual Investor Day February 13 at 3:00 p.m. ET
February 06, 2024
Via
ACCESSWIRE
3 Hidden-Gem Penny Stocks That Could Yield Life-Changing Wealth
February 05, 2024
Unlock the secret to wealth with insights on ZOM, SNDL, and BLDE. Discover how these penny stocks could redefine your future.
Via
InvestorPlace
Open Letter to Zomedica Shareholders from your Chief Executive Officer
January 31, 2024
Via
ACCESSWIRE
Zomedica to Participate in the Lytham Partners 2024 Investor Select Conference
January 30, 2024
Via
ACCESSWIRE
Leading Proxy Advisory Firm ISS Recommends Zomedica Shareholders Vote "FOR" Proposed Reverse Stock Split
January 25, 2024
Via
ACCESSWIRE
Zomedica Announces Preliminary 2023 Revenue; Provides Revenue Guidance for 2024, and Rationale for Share Consolidation ("Reverse Stock Split")
January 17, 2024
Via
ACCESSWIRE
3 Breakout Penny Stocks Primed for Massive Gains
January 16, 2024
Discover three penny stocks poised for breakout success in veterinary, liquor retail, and insurance sectors.
Via
InvestorPlace
Zomedica Corp. to Host Conference Call on January 17, 2024, at 4:30 p.m. ET to Provide a Business Update, Preliminary 2023 Revenue and Cash Position, and Discuss the Proposed Reverse Stock Split; Provides Notice of Special Virtual-Only Meeting of
January 10, 2024
Via
ACCESSWIRE
Budget Bets: Top 3 Penny Stocks with Potential for Explosive Growth
January 04, 2024
These cheap stocks offer investors an extreme risk to reward tradeoff, which might be worth considering for lucrative payoffs.
Via
InvestorPlace
Zomedica Announces Publication of Research Validating Better Patient Acceptance of PulseVet(R) Electro-hydraulic Shock Wave Therapy without Sedation Utilizing Novel “X-Trode” Handpiece
January 04, 2024
Via
ACCESSWIRE
Zomedica Announces Expansion of Market Opportunity for TRUFORMA(R) Diagnostic Platform with Launch of Three New Assays for Commonly Performed Diagnostic Tests for Canine Gastrointestinal Disease
December 18, 2023
Via
ACCESSWIRE
Zomedica Announces Presentation of Clinical Data in Support of New Indications for PulseVet Shock Wave Therapy at Annual Meeting of American Association of Equine Practitioners
December 06, 2023
Via
ACCESSWIRE
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.